The Boston Marathon Study: A Novel Approach to Research During Residency

Andrew Y. Shin(Harvard University), Elizabeth B. Fortescue(Harvard University), Christopher S. Almond(Stanford University), Mary Beth F. Son(Boston Children's Hospital), Usama Kanaan(Boston Children's Hospital), Pearl S. Riney(Boston Children's Hospital), Heather McLauchlan(Boston Children's Hospital), Rebekah Mannix(Boston Children's Hospital), Jennifer M. Litzow(Boston Children's Hospital), Cameron C. Trenor(Somerville Hospital), Robert J. Vinci(Boston Medical Center), David S. Greenes(Harvard University), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
PEDIATRICS
May 1, 2006
10.1542/peds.2005-1249
Cited by 17

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537